UnitedHealth Group Incorporated $UNH Shares Purchased by Williams & Novak LLC

Williams & Novak LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 114.4% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,441 shares of the healthcare conglomerate’s stock after buying an additional 769 shares during the quarter. Williams & Novak LLC’s holdings in UnitedHealth Group were worth $450,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. Bayforest Capital Ltd raised its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares during the period. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $42,000. Kentucky Trust Co increased its position in UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after acquiring an additional 50 shares during the period. Finally, O Brien Wealth Partners LLC increased its position in UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after acquiring an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the topic of several analyst reports. KeyCorp raised their target price on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Royal Bank Of Canada decreased their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Barclays increased their price target on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, Mizuho increased their price target on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $383.09.

UnitedHealth Group Stock Performance

UNH opened at $354.30 on Friday. The firm has a market cap of $320.88 billion, a PE ratio of 15.35, a P/E/G ratio of 2.38 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $318.21 and a 200-day simple moving average of $350.41. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.